Aqueous solubility of crystalline and amorphous drugs: Challenges in measurement (Q37739476)

22 August 2017

1 reference

title

Aqueous solubility of crystalline and amorphous drugs: Challenges in measurement (English)

1 reference

22 August 2017

Sharad B Murdande

1

1 reference

22 August 2017

Michael J Pikal

series ordinal

2

1 reference

22 August 2017

Ravi M Shanker

series ordinal

3

1 reference

22 August 2017

Robin H Bogner

series ordinal

4

1 reference

22 August 2017

30 April 2010

1 reference

Pharmaceutical Development and Technology

22 August 2017

1 reference

22 August 2017

16

1 reference

22 August 2017

3

1 reference

22 August 2017

187-200

1 reference

Solubility Determination of Barely Aqueous-Soluble Organic Solids

22 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

Drug polymorphism and dosage form design: a practical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

Spectral methods for the characterization of polymorphs and solvates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

Analytical techniques for quantification of amorphous/crystalline phases in pharmaceutical solids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

Disordered drug delivery: destiny, dynamics and the Deborah number

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

Impact of the amount of excess solids on apparent solubility.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

In vitro solubility assays in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

Comparative interaction of 2-hydroxypropyl-beta-cyclodextrin and sulfobutylether-beta-cyclodextrin with itraconazole: phase-solubility behavior and stabilization of supersaturated drug solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

Simulation modelling of human intestinal absorption using Caco-2 permeability and kinetic solubility data for early drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

Amorphization alone does not account for the enhancement of solubility of drug co-ground with silicate: the case of indomethacin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

Chasing equilibrium: measuring the intrinsic solubility of weak acids and bases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

Comparison of a miniaturized shake-flask solubility method with automated potentiometric acid/base titrations and calculated solubilities

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

pH-metric solubility. 3. Dissolution titration template method for solubility determination

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

pH-metric solubility. 2: correlation between the acid-base titration and the saturation shake-flask solubility-pH methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

Physicochemical profiling (solubility, permeability and charge state).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

Intrinsic solubility estimation and pH-solubility behavior of cosalane (NSC 658586), an extremely hydrophobic diprotic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

Dissolution and ionization of warfarin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

High throughput physicochemical profiling for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

Automated robotic liquid handling/laser-based nephelometry system for high throughput measurement of kinetic aqueous solubility

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

Solubility of E2050 at various pH: a case in which apparent solubility is affected by the amount of excess solid.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

Revisiting the carboxylic acid dimers in aqueous solution: interplay of hydrogen bonding, hydrophobic interactions, and entropy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

Physical stability and solubility advantage from amorphous celecoxib: the role of thermodynamic quantities and molecular mobility

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

A comparative assessment of solubility advantage from glassy and crystalline forms of a water-insoluble drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

Improving the solubility of ampelopsin by solid dispersions and inclusion complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

Improving drug solubility for oral delivery using solid dispersions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

Changes in surface properties by granulation and physicochemical stability of granulated amorphous cefditoren pivoxil with additives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

Stability study of amorphous valdecoxib

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

Hydrogen bonding with adsorbent during storage governs drug dissolution from solid-dispersion granules

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

The solid-state stability of amorphous quinapril in the presence of beta-cyclodextrins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

Stability and solubility of celecoxib-PVP amorphous dispersions: a molecular perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

Effect of polymer additives on the transformation of BMS-566394 anhydrate to the dihydrate form

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837451003774377

10.3109/10837451003774377

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference